Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia

Clinical Research in Cardiology

Volumn 97, Issue 11, 2008, Pages 811-819

  Zhang, R ^a   Haverich, A ^a   Struber M ^a   Simon, A ^a   Pichlmaier, M ^a   Bara, Christoph ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cardiovascular drugs; Exercise performance; Heart transplantation; Sinus tachycardia

Indexed keywords

AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EVEROLIMUS; IVABRADINE; METOPROLOL; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; AGED; ALLOGRAFT; ARTICLE; BLOOD ANALYSIS; BRADYCARDIA; CARDIAC GRAFT REJECTION; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DIZZINESS; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FATIGUE; FEMALE; HEART LEFT VENTRICLE MASS; HEART RATE; HEART TRANSPLANTATION; HUMAN; MALE; QT INTERVAL; SIDE EFFECT; SINUS TACHYCARDIA; VERTIGO; VISION;

ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; BENZAZEPINES; ELECTROCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART CONDUCTION SYSTEM; HEART TRANSPLANTATION; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TACHYCARDIA, SINUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 58549110625     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-008-0690-5     Document Type: Article

References (57)

1. F Beckers D Ramaekers G Speijer H Ector J Vanhaecke B Verheyden J Van Cleemput W Droogne F Van de Werf AE Aubert 2004 Different evolutions in heart rate variability after heart transplantation: 10-year follow-up Transplantation 78 1523 1531
2. A Berdeaux C Drieu La Rochelle V Richard JF Giudicelli 1991 Opposed responses of large and small coronary arteries to propranolol during exercise in dogs Am J Physiol Heart Circ Physiol 261 265 270
3. RS Bexton JR Milne R Cory-Pearce TA English AJ Camm 1983 Effect of beta blockade on exercise response after cardiac transplantation Br Heart J 49 584 588
4. P Bois J Bescond B Renaudon J Lenfant 1996 Mode of action of bradycardic agent, S16257, on ionic currents of rabbit sinoatrial node cells Br J Pharmacol 118 1051 1057
5. JS Borer K Fox P Jaillon G Lerebours 2003 Ivabradine Investigators Group. Anti-anginal and anti-ischemic effects of ivabradine, an If inhibitor, in stable angina: a randomized, double-blinded, multicentered, placebocontrolled trial Circulation 107 817 823
6. AS Bortone OM Hess A Gaglione T Suter H Nonogi J Grimm HP Krayenbuehl 1990 Effect of propranolol on coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium Circulation 81 1225 1235
7. M Burke A McGinn D Homans B Christensen S Kubo R Wilson 1995 Evidence for functional sympathetic reinnervation of left ventricle and coronary arteries after orthotopic cardiac transplantation in humans Circulation 91 72 78
8. AJ Camm CP Lau 2003 Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology Drugs R D 4 83 89
9. T DeMarco M Dae M Yuen-Green S Kumar K Sudhir F Keith T Amidon C Rifkin C Klinski D Lau E Botvinick K Chatterjee 1995 Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation J Am Coll Cardiol 25 927 931
10. D DiFrancesco 1986 Characterization of single pacemaker channels in cardiac sino-atrial node cells Nature 324 470 473
11. D DiFrancesco 1991 The contribution of the "pacemaker" current (If) to generation of spontaneous activity in rabbit sino-atrial node myocytes J Physiol 34 23 40
12. f current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease Drugs 64 1757 1765
13. R Fogari A Zoppi L Corradi A Mugellini L Poletti P Lusardi 1998 Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study Am J Hypertens 11 1244 1247
14. F Freytag A Schelling T Meinicke G Deichsel 2001 Telmisartan comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomised, multicenter study Clin Ther 23 108 123
15. SM Gardiner PA Kemp JE March T Bennett 1995 Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic agent, S16257, in conscious rats Br J Pharmacol 115 579 586
16. MM Givertz LH Hartley WS Colucci 1997 Long-term sequential changes in exercise capacity and chronotropic responsiveness after cardiac transplantation Circulation 96 232 237
17. T Hakamaki A Lehtonen 1997 Metabolic effects of spirapril and atenolol: results from a randomized, long-term study Int J Clin Pharmacol Ther 35 227 230
18. f improves symptoms in severe dilated cardiomyopathy Clin Res Cardiol 96 243 246
19. H Irisawa HF Brown W Giles 1993 Cardiac pacemaking in the sinoatrial node Physiol Rev 73 197 227
20. DL Kemp SH Jennison AM Stelken LT Younis LW Miller 1995 Association of resting heart rate and chronotropic response Am J Cardiol 75 751 752
21. DT Ko PR Hebert CS Coffey A Sedrakyan JP Curtis HM Krumholz 2002 Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction JAMA 288 351 357
22. J Koglin T Gross P Überfuhr W von Scheidt 1997 Time-dependent decrease of presynaptic inotropic supersensitivity: physiological evidence of sympathetic reinnervation after heart transplantation J Heart Lung Transplant 16 621 628
23. W Krone H Nagele 1988 Effects of antihypertensives on plasma lipids and lipoprotein metabolism Am Heart J 116 1729 1734
24. SS Kushwaha NR Banner N Patel A Cox H Patton MH Yacoub 1994 Effect of beta blockade on the neurohumoral and cardiopulmonary response to dynamic exercise in cardiac transplant recipients Br Heart J 71 431 436
25. AJ Labovitz AM Drimmer LR McBride DG Pennington VL Willman LW Miller 1989 Exercise capacity during the first year after cardiac transplantation Am J Cardiol 64 642 645
26. H Lithell T Pollare B Vessby 1992 Metabolic effects of pindolol and propranolol in a double-blind crossover study in hypertensive patients Blood Pressure 1 92 101
27. L Lopez-Bescos S Filipova R Martos 2007 Long-term safety and efficacy of ivabradine in patients with chronic stable angina Cardiology 108 387 396
28. A Luchner JC Burnett Jr M Jougasaki HW Hense IM Heid F Muders GA Riegger H Schunkert 2000 Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population J Hypertens 18 1121 1128
29. JS Mandak KD Aaronson DM Mancini 1995 Serial assessment of exercise capacity after heart transplantation J Heart Lung Transplant 14 468 478
30. M Manz M Reuter G Lauck H Omran W Jung 2003 A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction Cardiology 100 149 155
31. X Monnet P Colin B Ghaleh L Hittinger J-F Giudicelli A Berdeaux 2004 Heart rate reduction during exercise-induced myocardial ischaemia and stunning Eur Heart J 25 579 586
32. X Monnet B Ghaleh P Colin OP de Curzon J-F Giudicelli A Berdeaux 2001 Effect of heart rate reduction with ivabradine on exercise induced myocardial ischaemia and stunning J Pharmacol Exp Ther 299 1133 1139
33. P Mulder S Barbier A Chagraoui V Richard JP Henry F Lallemand S Renet G Lerebours F Mahlberg-Gaudin C Thuillez 2004 Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure Circulation 109 13 1674 1679
34. N Osada BR Chaitman TJ Donohue TL Wolford AM Stelken LW Miller 1997 Long-term cardiopulmonary exercise performance after heart transplantation Am J Cardiol 79 451 456
35. WJ Paulus JGF Bronzwaer H Felice N Kishan F Wellens 1992 Deficient acceleration of left ventricular relaxation during exercise after heart transplantation Circulation 86 1175 1185
36. R Perini C Orizio A Gamba A Veicsteinas 1993 Kinetics of heart rate and catecholamines during exercise in humans. The effect of heart denervation Eur J Appl Physiol Occup Physiol 66 500 506
37. RJ Quigg MB Rocco DF Gauthier MA Creager LH Hartley WS Colucci 1989 Mechanism of the attenuated peak heart rate response to exercise after orthotopic cardiac transplantation J Am Coll Cardiol 14 338 344
38. I Ragueneau C Laveille R Jochemsen G Resplandy C Funck-Brentano P Jaillon 1998 Pharmacokinetic-pharmacodynamic modeling of the effects of ivabradine, a direct sinus node inhibitor, on heart rate in healthy volunteers Clin Pharmacol Ther 64 192 203
39. J-C Reil M Böhm 2007 The role of heart rate in the development of cardiovascular disease Clin Res Cardiol 96 585 592
40. C Reithmann T Remp H Netz G Steinbeck 2007 Atrial tachycardias in a growing donor right atrium after pediatric heart transplantation Clin Res Cardiol 96 569 574
41. R Reneland E Alvarez P-E Andersson A Haenni L Byberg H Lithell 2000 Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolapril J Hum Hypertens 14 175 180
42. W Ruzyllo M Tendera I Ford KM Fox 2007 Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial Drugs 67 393 405
43. D Sahn A DeMaria J Kisslo A Weyman 1978 Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements Circulation 58 1072 1083
44. I Savelieva AJ Camm 2005 Absence of direct effects of the If current blocker ivabradine on ventricular repolarization: analysis based on a population heart rate correction formula. (Abstract) J Am Coll Cardiol 45 95A
45. U Scherrer SF Vissing HJ Morgan JA Rollins RS Tindall S Ring P Hanson PK Mohanty RG Victor 1990 Cyclosporine-induced sympathetic activation and hypertension after heart transplantation N Engl J Med 323 693 699
46. S Schuler D Thomas M Thebken U Frei T Wagner H Warnecke R Hetzer 1987 Endocrine response to exercise in cardiac transplant patients Transplant Proc 19 2506 2509
47. M Schwaiblmair W von Scheidt P Uberfuhr S Ziegler M Schwaiger B Reichart C Vogelmeier 1999 Functional significance of cardiac reinnervation in heart transplant recipients J Heart Lung Transplant 18 838 845
48. CD Scott JM McComb JH Dark 1993 Heart rate and late mortality in cardiac transplant recipients Eur Heart J 14 530 533
49. L Simon B Ghaleh L Puybasset JF Giudicelli A Berdeaux 1995 Coronary and hemodynamic effects of S16257, a new bradycardic agent, in resting and exercising conscious dogs J Pharmacol Exp Ther 275 659 666
50. JR Stratton GJ Kemp RC Daly SM Yacoub B Rajagopalan 1994 Effects of cardiac transplantation on bioenergetic abnormalities of skeletal muscle in congestive heart failure Circulation 89 1624 1631
51. MJ Tafreshi AB Weinacher 1999 Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma Pharmacotherapy 19 974 978
52. JC Tardif I Ford M Tendera MG Bourassa 2005 Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina Eur Heart J 26 2529 2536
53. C Thollon C Cambarrat J Vian JF Prost JL Peglion JP Vilaine 1994 Electrophysiological effects of S 16257, a novel sino-atrial node Pharmacol modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49 Br J Pharmacol 112 37 42
54. BL Troy J Pombo CE Rackley 1972 Measurement of left ventricular wall thickness and mass by echocardiography Circulation 45 602 611
55. BF Uretsky 1990 Physiology of the transplanted heart Cardiovasc Clin 20 23 56
56. MS Verani S Nishimura JJ Mahmarian JT Hays JB Young 1994 Cardiac function after orthotopic heart transplantation: response to postural changes, exercise, and beta-adrenergic blockade J Heart Lung Transplant 13 181 193
57. B Vrtovec R Radovancevic CD Thomas AP Yazdabakhsh FW Smart B Radovancevic 2006 Prognostic value of the QTc interval after cardiac transplantation J Heart Lung Transplant 25 29 35